Chimeric Therapeutics Limited (ASX:CHM)
Australia · Delayed Price · Currency is AUD 0.0030
0.00 (0.00%)
Sep 30, 2026, 4:11 PM AEST
Chimeric Therapeutics Market Cap
Chimeric Therapeutics has a market cap or net worth of 354.39 thousand as of October 19, 2026. It is the 50,874th most valuable company in the world and the 1,695th biggest in Australia. Its market cap has decreased by 96.37% in one year.
Market Cap
354.39K
Enterprise Value
215.46K
Revenue
-189.85K
Global Rank
Country Rank
#1,695 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since January 18, 2021, Chimeric Therapeutics's market cap has decreased from 97.50M to 354.39K, a decrease of -99.64%. That is a compound annual growth rate of -62.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 590.64K | -92.81% |
| Dec 31, 2025 | 8.22M | -25.46% |
| Dec 31, 2024 | 11.02M | -56.60% |
| Dec 29, 2023 | 25.40M | -27.35% |
| Dec 30, 2022 | 34.97M | -59.93% |
| Dec 31, 2021 | 87.26M | -10.51% |
| Jan 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immuron | 10.98M |
| Invex Therapeutics | 7.89M |
| Acrux | 7.08M |
| Vectus Biosystems | 6.53M |
| Zelira Therapeutics | 5.95M |
| Bio-Gene Technology | 5.69M |
| Biotron | 5.57M |
| Tissue Repair | 5.14M |